Cleveland Jewish News: William Schiemann, associate professor of general medical sciences, led a team of researchers who found a link between a micro ribonucleic acid molecule and late-stage breast cancer. “Our micro RNA inactivates [a protein called] Bim, and we think this leads to chemo resistance to these metastatic cancers,” Schiemann said. Lower Bim levels, coupled with higher miR-181a levels, allow the spread of cancer.
Medicine’s William Schiemann and researchers target molecule’s role in late-stage breast cancer
- Attend the 41st annual Ebony Ball Dec. 6; get tickets now
- Action required for voicemail users this Winter Break
- Submit original works to Art of STEM competition, exhibit at Kelvin Smith Library
- Learn about impact of design in today’s corporate world at Dec. 2 presentation
- Platelet mimicry technology halts bleeding faster, may have broad use in medicine